News
It’s a match! RNA sequencing and the future of oncology management
Katie Gordon | BioTechniques | Dec. 11, 2019 As well as providing more detailed information on a tumor’s genetic changes, RNA sequencing could provide an option to tailor treatments for more difficult to treat cases, such as those where genetic information is harder...
RNA Sequencing May Be Able to Help Target Therapies for Pediatric Cancers
Comparative RNA sequencing analysis, conducted across four precision medicine studies, was feasible and potentially useful for 68% of children with cancer Laura Joszt | AJMC | November 16, 2019 Genomic profiling of tumors has become standard in oncology, but tumors in...
UC Santa Cruz receives $400,000 grant for pediatric cancer research
Funds support the Treehouse Childhood Cancer Initiative in improving clinical care and treatment option Elaine Ingalls | Santa Cruz Sentinel | August 16, 2019 SANTA CRUZ — UC Santa Cruz has received $400,000 as one of 55 grants from the St. Baldrick’s Foundation for...
St. Baldrick’s Foundation grant funds Treehouse Childhood Cancer Initiative
Emily Beazley Kures for Kids Fund Hero Award provides $400,000 for efforts at UC Santa Cruz to bring comparative genomics analysis to pediatric cancer patients Tim Stephens | UC Santa Cruz | July 23, 2019 The St. Baldrick's Foundation, the largest private funder of...
NCI Pediatric MATCH Trial Interim Data Shows 24 Percent of Patients Eligible for Targeted Therapy
May 16, 2019 | Christie Rizk | GenomeWeb NEW YORK – An interim analysis of the National Cancer Institute-Children's Oncology Group (NCI-COG) Pediatric Molecular Analysis for Therapy Choice (MATCH) study — a precision medicine clinical trial for pediatric cancer — has...